^
BIOMARKER:
MYC rearrangement + BCL2 rearrangement
i
Other names: MYC, bHLHe39, c-Myc, MYCC, V-myc avian myelocytomatosis viral oncogene homolog, BCL2, Bcl-2, PPP1R50, B-cell CLL/lymphoma 2
Entrez ID:
MYC rearrangement + BCL2 rearrangement
Diffuse Large B Cell Lymphoma
lisocabtagene maraleucel
Sensitive
:
A2
MYC rearrangement + BCL2 rearrangement
Diffuse Large B Cell Lymphoma
lenalidomide
Sensitive
:
B
MYC rearrangement + BCL2 rearrangement
Diffuse Large B Cell Lymphoma
cytarabine + methotrexate
Resistant
:
C3
MYC rearrangement + BCL2 rearrangement
Diffuse Large B Cell Lymphoma
rituximab
Resistant
:
C3
MYC rearrangement + BCL2 rearrangement
Lymphoma
lisocabtagene maraleucel
Sensitive
:
C3
MYC rearrangement + BCL2 rearrangement
NHL
ibrutinib
Sensitive
:
C3
MYC rearrangement + BCL2 rearrangement
Follicular Lymphoma
EPOCH-R
Sensitive
:
C3
MYC rearrangement + BCL2 rearrangement
Follicular Lymphoma
R-DHAP
Sensitive
:
C3
MYC rearrangement + BCL2 rearrangement
Diffuse Large B Cell Lymphoma
IACS-010759
Sensitive
:
D
MYC rearrangement + BCL2 rearrangement
Diffuse Large B Cell Lymphoma
ibrutinib
Resistant
:
D
MYC rearrangement + BCL2 rearrangement
NHL
ibrutinib + alemtuzumab
Sensitive
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our